Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/17/26 18:27 | 2/15/26 | MGNX | Health | Drug | Pharmaceutical Preparations | Bonvini Ezio | MD | O | SVP,Rese | 2 | M.dm | 0 | 0.00 | 0 | 35 | 31 | 146 | D | ||||||||||||||
2/17/26 18:26 | 2/15/26 | MGNX | Health | Drug | Pharmaceutical Preparations | Smith Beth Ann | MD | O | VP,Contr | 2 | M.dm | 0 | 0.00 | 0 | 5 | 71 | 13 | D | ||||||||||||||
2/17/26 18:25 | 2/15/26 | MGNX | Health | Drug | Pharmaceutical Preparations | Karrels James | MD | O | SVP,CFO | 2 | M.dm | 0 | 0.00 | 0 | 31 | 18 | 206 | D | ||||||||||||||
2/17/26 18:25 | 2/15/26 | MGNX | Health | Drug | Pharmaceutical Preparations | Peters Jeffrey Stuart | MD | O | SVP,GC,, | 2 | M.dm | 0 | 0.00 | 0 | 28 | 999% | 31 | D | ||||||||||||||
2/17/26 18:24 | 2/15/26 | MGNX | Health | Drug | Pharmaceutical Preparations | Spitznagel Thomas | MD | O | SVP,Tech | 2 | M.dm | 0 | 0.00 | 0 | 28 | 277 | 39 | D | ||||||||||||||
2/17/26 18:23 | 2/15/26 | MGNX | Health | Drug | Pharmaceutical Preparations | Risser Eric Blasius | MD | DO | P ,CEO | 2 | M.dm | 0 | 0.00 | 0 | 34 | 81 | 77 | D | ||||||||||||||
2/17/26 18:22 | 2/15/26 | MGNX | Health | Drug | Pharmaceutical Preparations | Koenig Scott | MD | D | 2 | M.d | 0 | 0.00 | 0 | 37 | 4 | 867 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |